Chronic Kidney Disease (CKD) patients can experience a range of possible disease outcomes; however, physicians currently have a limited ability to predict individual patient outcomes and treat patients accordingly. The PROOF Centre is discovering and developing panels of blood biomarkers to help clinicians to distinguish patients with rapidly progressive disease from patients with stable or slowly progressive disease. These tests will allow physicians to implement patient- and time-appropriate treatment plans for individual CKD patients.

Click here to read more about our CKD program.

PROOF Fact Sheet - Programs CKD 20140805_Page_1